Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Heart, Lung & Circulation
|
August 30, 2020
CSANZ COVID-19 Cardiovascular Nursing Care Consensus Statement: Executive Summary
Sally C Inglis, Carolyn Naismith, Kevin White, et al.
Journal of Medical Internet Research
|
March 12, 2026
Creation of EmpowerMe Website to Promote Self-Efficacy in Survivors of Stroke: Co-Design Study
Elizabeth A Lynch, Adrian O'Malley, Zoe Adey-Wakeling, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Cancer Research
|
September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells
Teemu T Junttila, Ji Li, Jennifer Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 2013
Development and preclinical characterization of a humanized antibody targeting CXCL12
Cuiling Zhong, Jianyong Wang, Bing Li, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Science Translational Medicine
|
May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
Liping L Sun, Diego Ellerman, Mary Mathieu, et al.
JCI Insight
|
April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
Karin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
Peiyin Wang, Liping L Sun, Robyn Clark, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Heart, Lung & Circulation
|
August 30, 2020
CSANZ COVID-19 Cardiovascular Nursing Care Consensus Statement: Executive Summary
Sally C Inglis, Carolyn Naismith, Kevin White, et al.
Journal of Medical Internet Research
|
March 12, 2026
Creation of EmpowerMe Website to Promote Self-Efficacy in Survivors of Stroke: Co-Design Study
Elizabeth A Lynch, Adrian O'Malley, Zoe Adey-Wakeling, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Cancer Research
|
September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells
Teemu T Junttila, Ji Li, Jennifer Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 2013
Development and preclinical characterization of a humanized antibody targeting CXCL12
Cuiling Zhong, Jianyong Wang, Bing Li, et al.
Cancer Cell
|
October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies
Gabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Science Translational Medicine
|
May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
Liping L Sun, Diego Ellerman, Mary Mathieu, et al.
JCI Insight
|
April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
Karin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
Peiyin Wang, Liping L Sun, Robyn Clark, et al.
Cancer Immunology, Immunotherapy : CII
|
August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Page
of 6